Synonyms: Isentress® | MK-0518 | MK0518
raltegravir is an approved drug (EMA & FDA (2007))
Compound class:
Synthetic organic
Comment: Raltegravir (MK-0518) is an HIV integrase inhibitor (integrase strand transfer inhibitor) [1].
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes (EMA & FDA (2007)) |
WHO Essential Medicine | WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version. Click to view more information about the WHO Model Lists of Essential Medicines. |
International Nonproprietary Names | |
INN number | INN |
8842 | raltegravir |
Synonyms |
Isentress® | MK-0518 | MK0518 |
Database Links | |
BindingDB Ligand | 25351 |
CAS Registry No. | 518048-05-0 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL254316 |
DrugBank Ligand | DB06817 |
GtoPdb PubChem SID | 441604943 |
PubChem CID | 54671008 |
RCSB PDB Ligand | RLT |
Search Google for chemical match using the InChIKey | CZFFBEXEKNGXKS-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | CZFFBEXEKNGXKS |
Search PubMed clinical trials | raltegravir |
Search PubMed titles | raltegravir |
Search PubMed titles/abstracts | raltegravir |
UniChem Compound Search for chemical match using the InChIKey | CZFFBEXEKNGXKS-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | CZFFBEXEKNGXKS-UHFFFAOYSA-N |